未登录
分享
收藏Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery Platform
Metcalf, Chester A., III; Svenson, Sonke; Hwang, Jungyeon; Tripathi, Snehlata; Gangal, Geeti; Kabir, Sujan; Lazarus, Douglas; Cole, Roderic; Sweryda-Krawiec, Beata; Shum, Pochi; Brown, Donna; Case, Roy I.; van der Poll, Derek; Rohde, Ellen; Harlfinger, Stephanie; Teng, Chi-Hse; Eliasof, Scott
分享
收藏
分享
收藏
分享
收藏Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Eliasof, Scott; Lazarus, Douglas; Peters, Christian G.; Case, Roy I.; Cole, Roderic O.; Hwang, Jungyeon; Schluep, Thomas; Chao, Joseph; Lin, James; Yen, Yun; Han, Han; Wiley, Devin T.; Zuckerman, Jonathan E.; Davis, Mark E.
分享
收藏First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
Weiss, Glen J.; Chao, Joseph; Neidhart, Jeffrey D.; Ramanathan, Ramesh K.; Bassett, Dawn; Neidhart, James A.; Choi, Chung Hang J.; Chow, Warren; Chung, Vincent; Forman, Stephen J.; Garmey, Edward; Hwang, Jungyeon; Kalinoski, D. Lynn; Koczywas, Marianna; Longmate, Jeffrey; Melton, Roger J.; Morgan, Robert; Oliver, Jamie; Peterkin, Joanna J.; Ryan, John L.; Schluep, Thomas; Synold, Timothy W.; Twardowski, Przemyslaw; Davis, Mark E.; Yen, Yun
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏